Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Gilligan

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
Clinical Genitourinary Cancer|March 27, 2018
Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal FunctionVadim S Koshkin, Pedro C Barata, Lisa A Rybicki, et al.
Journal for Immunotherapy of Cancer|January 31, 2018
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinomaVadim S Koshkin, Pedro C Barata, Tian Zhang, et al.
The Journal of Urology|March 28, 2015
A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal ParenchymaBrian I Rini, Elizabeth R Plimack, Toshio Takagi, et al.
Clinical Genitourinary Cancer|March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial CarcinomaHamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
The American Journal of Surgical Pathology|February 22, 2026
International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting SurveyFelix Bremmer, Maurizio Colecchia, Katrina Collins, et al.
Clinical Genitourinary Cancer|April 29, 2020
Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall SurvivalJaleh Fallah, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic TargetVadim S Koshkin, Jorge A Garcia, Jordan Reynolds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyTimothy Gilligan, Daniel W Lin, Rahul Aggarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2025
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025Timothy Gilligan, Daniel W Lin, Nabil Adra, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
Clinical Genitourinary Cancer|March 27, 2018
Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal FunctionVadim S Koshkin, Pedro C Barata, Lisa A Rybicki, et al.
Journal for Immunotherapy of Cancer|January 31, 2018
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinomaVadim S Koshkin, Pedro C Barata, Tian Zhang, et al.
The Journal of Urology|March 28, 2015
A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal ParenchymaBrian I Rini, Elizabeth R Plimack, Toshio Takagi, et al.
Clinical Genitourinary Cancer|March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial CarcinomaHamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
The American Journal of Surgical Pathology|February 22, 2026
International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting SurveyFelix Bremmer, Maurizio Colecchia, Katrina Collins, et al.
Clinical Genitourinary Cancer|April 29, 2020
Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall SurvivalJaleh Fallah, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic TargetVadim S Koshkin, Jorge A Garcia, Jordan Reynolds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyTimothy Gilligan, Daniel W Lin, Rahul Aggarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2025
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025Timothy Gilligan, Daniel W Lin, Nabil Adra, et al.
Pageof 7